Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential

Expert Opinion on Pharmacotherapy
Michael Soyka

Abstract

Few pharmacotherapies are available for alcoholism. Numerous studies indicate the involvement of the opioid-endorphin system in mediating the reinforcing effects of alcohol via dopaminergic neurons. The opioid antagonist naltrexone was found to be effective in alcohol treatment, and the European Medicines Agency has now approved the mu-opioid antagonist und partial kappa agonist nalmefene. This article presents background information on the chemistry of nalmefene and pre-clinical and clinical findings. The three relevant Phase III studies, all of which followed a harm-reduction, "as needed" approach and found reduced alcohol consumption with nalmefene 18 (20) mg, are discussed in detail. The integration of the "as needed" approach into conventional psychosocial alcohol therapies may be challenging but offers the opportunity to reach otherwise not treated patients. Nalmefene is the first medication to be approved specifically in this indication and seems to be most suitable for patients with alcohol misuse or a rather low physical dependence on alcohol who do not require immediate detoxification or inpatient treatment. Although a categorical distinction between patients who want to stop heavy drinking or drinking at all over tim...Continue Reading

References

May 1, 1992·Trends in Pharmacological Sciences·G F Koob
Nov 1, 1986·Clinical Pharmacology and Therapeutics·T J GalR Dixon
Mar 1, 1987·Journal of Clinical Pharmacology·R DixonD Weidler
Oct 1, 1994·Alcoholism, Clinical and Experimental Research·B J MasonE Mantero-Atienza
Jan 1, 1997·Psychopharmacology·A Herz
May 1, 1997·Addictive Behaviors·H R KranzlerM J Bohn
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·C BondL Yu
Aug 6, 1999·Archives of General Psychiatry·B J MasonR B Cutler
Dec 3, 1999·Progress in Neuro-psychopharmacology & Biological Psychiatry·M S Cowen, A J Lawrence
Sep 13, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Roberto CiccocioppoFriedbert Weiss
Mar 26, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David J DrobesKonstantin Voronin
Aug 14, 2003·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Mats Berglund, Sten Thelander
Feb 3, 2004·Current Topics in Medicinal Chemistry·Christina Gianoulakis
Feb 20, 2004·The American Journal on Addictions·John Littleton, Walter Zieglgänsberger
May 26, 2004·Physiology & Behavior·L M Oswald, G S Wand
Jul 3, 2004·Journal of Clinical Psychopharmacology·Raymond F AntonSakari Karhuvaara
Sep 15, 2004·Alcoholism, Clinical and Experimental Research·David J DrobesKonstantin Voronin
Jan 28, 2005·The Cochrane Database of Systematic Reviews·M Srisurapanont, N Jarusuraisin
Feb 8, 2005·Trends in Molecular Medicine·Jörn Lötsch, Gerd Geisslinger
Jun 1, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jürgen RehmFrank Jacobi
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kimmo IngmanHarry Scheinin
Jul 1, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gavin BartMary Jeanne Kreek
Feb 24, 2006·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Sami P PirkolaJouko K Lönnqvist
Mar 21, 2006·Pharmacology & Therapeutics·Markus Heilig, Mark Egli
Apr 26, 2006·Alcoholism, Clinical and Experimental Research·Carlos A Hernandez-AvilaHenry R Kranzler
May 6, 2006·Neuron·R Alison AdcockJohn D E Gabrieli
Mar 7, 2007·Clinical Pharmacology and Therapeutics·Andrew A SomogyiJanet K Coller
May 3, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Brendan M Walker, George F Koob
Feb 12, 2008·Trends in Pharmacological Sciences·Rainer Spanagel, Falk Kiefer
Feb 15, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael SoykaUNKNOWN WFSBP Task Force on Treatment Guidelines for Substance Use Disorders
Jun 10, 2008·Alcoholism, Clinical and Experimental Research·Albert J AriasHenry R Kranzler
Jul 15, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Tim M WilliamsAnne Lingford-Hughes
Sep 11, 2009·Addiction Biology·Valentina VengelieneRainer Spanagel
Feb 18, 2010·Life Sciences·Melissa D OsbornEdward J Bilsky
May 18, 2010·Integrative Biology : Quantitative Biosciences From Nano to Macro·Pravin K NaoghareJoon Myong Song
Jun 22, 2010·Expert Opinion on Emerging Drugs·Michael Soyka, Susanne Rösner
Sep 9, 2010·The Cochrane Database of Systematic Reviews·Susanne RösnerMichael Soyka
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Susanne RösnerMichael Soyka

❮ Previous
Next ❯

Citations

Dec 23, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael SoykaUNKNOWN WFSBP Task Force on Treatment Guidelines for Substance Use Disorders
Aug 19, 2016·BMC Medicine·Florian NaudetBruno Laviolle
May 15, 2016·CNS Neuroscience & Therapeutics·Benjamin RollandHenri-Jean Aubin
Mar 23, 2017·Fundamental & Clinical Pharmacology·Melissa Yéléhé-OkoumaPierre Gillet
Jul 1, 2017·Expert Opinion on Pharmacotherapy·Michael Soyka, Christian A Müller
Mar 2, 2018·Psychopharmacology·Johanna Uhari-VäänänenPetteri Piepponen
Jan 4, 2019·Expert Opinion on Pharmacotherapy·Thomas Hillemacher, Helge Frieling
Mar 3, 2018·Psychopharmacology·Laura B FergusonRoy Dayne Mayfield
Jun 5, 2019·Expert Opinion on Drug Metabolism & Toxicology·Emily E Hartwell, Henry R Kranzler
Jul 23, 2020·Der Nervenarzt·Michael Soyka, Susanne Rösner
Mar 30, 2018·Frontiers in Physiology·Rajeswari KoyyadaStefano O Casalotti
Mar 27, 2018·Psychopharmacology·Erin J CampbellChristina J Perry
Aug 7, 2019·Alcoholism, Clinical and Experimental Research·Erica N Grodin, Lara A Ray
May 28, 2019·Frontiers in Pharmacology·Jerome Clifford FooRainer Spanagel
May 26, 2017·Advances in Therapy·Marco Di NicolaLuigi Janiri
Feb 23, 2021·Expert Opinion on Pharmacotherapy·Kirsten C MorleyPaul Haber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alcohol Use Disorder

Alcohol use disorder involves a pattern of alcohol consumption that includes compulsive use and a loss of control over intake of alcohol. The impact on physical health, socioeconomic factors, and psychiatric health is profound. Find the latest research on alcohol use disorder here.

Related Papers

The International Journal of Neuropsychopharmacology
Michael Soyka
Progress in Neuro-psychopharmacology & Biological Psychiatry
Michael Soyka, Jochen Mutschler
Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism
J R VolpicelliC P O'Brien
© 2021 Meta ULC. All rights reserved